Does anticoagulation alter your decision for elective nodal radiation in a prostate cancer patient?  

Would you be less likely to recommend in a patient? Are there any increased vascular, GI or GU risks? Any strategies you employ to mitigate risks?



Answer from: Radiation Oncologist at Academic Institution